| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/24/2005 | WO2004109290A3 Methods for identifying modulators of kinesin activity |
| 03/24/2005 | WO2004108079A3 Parkin-interacting proteins |
| 03/24/2005 | WO2004106885A3 Battery pack of a mobile communication terminal to be capable of reading output of bio-sensors and self-diagnosis system |
| 03/24/2005 | WO2004105681A3 Cd4+ human papillomavirus (hpv) epitopes |
| 03/24/2005 | WO2004102193A3 Detection of biochemical interactions on a biosensor using tunable filters and tunable lasers |
| 03/24/2005 | WO2004099384A3 Solid phase cell lysis and capture platform |
| 03/24/2005 | WO2004097426A3 Methods and means for the treatment of disorders associated with cellular senescence |
| 03/24/2005 | WO2004097399A3 Device and method for measuring the concentration of a pollutant in gaseous effluents |
| 03/24/2005 | WO2004097370A3 Systems and methods for monitoring chemical and biolgical activities using differential measurements |
| 03/24/2005 | WO2004097367A3 Chromogenic substrate with a ph indicator dye |
| 03/24/2005 | WO2004094673A3 Methods for monitoring drug activities in vivo |
| 03/24/2005 | WO2004092718A3 Gamma ray detectors with coincidence circuit for a logging tool and their use in analyzing materials in an oil well |
| 03/24/2005 | WO2004092322A3 Devices and assays for monitoring/measuring cellular dynamics to create subject profiles from primary cells |
| 03/24/2005 | WO2004089187A3 Caries risk test for predicting and assessing the risk of disease |
| 03/24/2005 | WO2004088325A3 Determination of proteins and/or other molecules using mass spectroscopy |
| 03/24/2005 | WO2004088312A3 Fluorescently tagged ligands |
| 03/24/2005 | WO2004087299A3 Liquid absorptometry method of providing product consistency |
| 03/24/2005 | WO2004086020A3 Application specific integrated circuitry for controlling analysis of a fluid |
| 03/24/2005 | WO2004085463A3 Methods of unnatural amino acid incorporation in proteins in mammalian cells |
| 03/24/2005 | WO2004083385A3 Quorum sensing signaling in bacteria |
| 03/24/2005 | WO2004078934A3 Targeting site-2 protease (s2p) for the treatment of pancreatic cancer |
| 03/24/2005 | WO2004072097A3 A microchip-based system for hiv diagnostics |
| 03/24/2005 | WO2004071269A3 Gene marker and composition for diagnosis and treatment of neurological disorders and diseases and use of the same |
| 03/24/2005 | WO2004069860A3 Isg15-conjugated proteins |
| 03/24/2005 | WO2004069175A3 METHODS AND COMPOSITIONS FOR THE TREATMENT OF PARKINSON’S DISEASE AND OTHER α-SYNUCLEINOPATHIES |
| 03/24/2005 | WO2004068931A3 Amphiregulin antibodies and their use to treat cancer and psoriasis |
| 03/24/2005 | WO2004068511A3 Formation of superparamagnetic particles |
| 03/24/2005 | WO2004065569A3 Multi-functional antibodies |
| 03/24/2005 | WO2004060925A3 Multiplex polymer ligation |
| 03/24/2005 | WO2004056309A3 Neuroprotective activity of activated protein c is independent of its anticoagulant activity |
| 03/24/2005 | WO2004053142A3 P53-associated parkin-like cytoplasmic protein, and related compositions and methods |
| 03/24/2005 | WO2004048546A3 Methods for identifying risk of breast cancer and treatments thereof |
| 03/24/2005 | WO2004047761A3 Mbcats as modifiers of the beta-catenin pathway and methods of use |
| 03/24/2005 | WO2004047746A3 Regulation of stearoyl-coa desaturase to treat obesity |
| 03/24/2005 | WO2004041177A3 Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells |
| 03/24/2005 | WO2004040302A8 REGULATION OF INTERACTION BETWEEN RAPL AND Rap1 |
| 03/24/2005 | WO2004038400A3 Phased sensor system with multiple parallel preconcentrators |
| 03/24/2005 | WO2004034025A3 Nano-chem-fet based biosensors |
| 03/24/2005 | WO2004033654A3 Automated method for high throughput screening of nematodes |
| 03/24/2005 | WO2004027540A3 A computational method for predicting intramolecular and intermolecular biopolymer interactions |
| 03/24/2005 | WO2004025270A3 Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-atherogenesis |
| 03/24/2005 | WO2004012683A9 Novel druggable regions in set domain proteins and methods of using the same |
| 03/24/2005 | WO2003103478A3 Methods for using adamts-12, an integrin and metalloprotease with thrombospondin motifs |
| 03/24/2005 | WO2003101176A3 Method, composition and kit for antigenic binding of norwalk-like viruses |
| 03/24/2005 | WO2003094856A3 1l1rl-1 as a cardiovascular disease marker and therapeutic target |
| 03/24/2005 | WO2003087134A3 G-protein coupled receptor ligands and methods |
| 03/24/2005 | WO2003083469A3 Integrated sample testing meter |
| 03/24/2005 | WO2003083067A3 Histone deacetylase inhibitors for the treatment of multiple sclerosis, amyotrophic lateral sclerosis and alzheimer's disease |
| 03/24/2005 | WO2003074548A8 Phage ligand sensor devices and uses thereof |
| 03/24/2005 | WO2003072746A3 Subtilisin carlsberg proteins with reduced immunogenicity |
| 03/24/2005 | WO2003048786A3 Pipette configurations and arrays thereof for measuring cellular electrical properties |
| 03/24/2005 | WO2002092759A9 Molecules for disease detection and treatment |
| 03/24/2005 | WO2002058450A3 Regulation of cell growth by muc1 |
| 03/24/2005 | US20050066378 Transgenic animal comprising gene which induces lymphoproliferation for use as tool in generating autoantibodies for detection and treatment of autoimmune diseases; immunotherapy |
| 03/24/2005 | US20050065759 Lumping and delumping method for describing hydrocarbon-containing fluids |
| 03/24/2005 | US20050065741 Sensor platform using a non-horizontally oriented nanotube element |
| 03/24/2005 | US20050065738 Methods and apparatus for characterizing polymeric mixtures |
| 03/24/2005 | US20050065737 genotypically and phenotypically characterizing a sample of a population |
| 03/24/2005 | US20050065736 Systems and methods for improving efficiencies in livestock production |
| 03/24/2005 | US20050065733 Visualization of databases |
| 03/24/2005 | US20050065732 Matrix methods for quantitatively analyzing and assessing the properties of botanical samples |
| 03/24/2005 | US20050065446 Methods of collecting and analyzing human breath |
| 03/24/2005 | US20050065415 Optical measurement apparatus and blood sugar level measuring apparatus using the same |
| 03/24/2005 | US20050065325 Monoclonal antibody for use as diagnostic and therapeutic tool in treatment and prevention of cell proliferative and degenerative bone disorders |
| 03/24/2005 | US20050065324 Aggrecanase for use prognostic and/or diagnostic indicator of cell proliferative disorders |
| 03/24/2005 | US20050065321 Cytokine receptor (Zcytor16) for use as tool in prevention and treatment of cell proliferative and nervous system disorders |
| 03/24/2005 | US20050065288 Process for producing particles for diagnostic reagent |
| 03/24/2005 | US20050065230 Matrix with imprinting cavities and bound macromolecules; microarrays for screening, binding target molecules |
| 03/24/2005 | US20050065184 Using angiotensin converting enzyme inhibitor; cardiovascular disorders; antidiabetic agentsd |
| 03/24/2005 | US20050065162 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 03/24/2005 | US20050065084 polynucleotide codes for saratin polypeptides from saliva of leeches, used as antagonist for collagen-dependent platelet adhesion; genetic engineering; prophylaxis of cardiovascular disorders |
| 03/24/2005 | US20050065081 Using a protein; diagnosis, therapy cancer |
| 03/24/2005 | US20050065077 Anticarcinogenic agents |
| 03/24/2005 | US20050065076 Gamma three protease |
| 03/24/2005 | US20050065062 Method of formulating a pharmaceutical composition |
| 03/24/2005 | US20050064604 Assay based on doped nanoparticles |
| 03/24/2005 | US20050064603 Using temperature variance as tool in detection of preferential bioparticles in solution |
| 03/24/2005 | US20050064601 Using thin layer chromatography to identify components of explosives |
| 03/24/2005 | US20050064600 Detection method and apparatus |
| 03/24/2005 | US20050064596 Buffer solution for electroporation and a method comprising the use of the same |
| 03/24/2005 | US20050064594 Transgenic liver cell for use as tool in diagnosis, prevention and treatment of viral diseases; viricides and receptor binding activity |
| 03/24/2005 | US20050064593 Expression vector comprising breast cancer gene (BCL-2) nucleotide sequences for use as tool in treatment, diagnosis and prevention of cell proliferative disorders |
| 03/24/2005 | US20050064585 Apparatus comprising two endcapping sections and a hollow fibre filter for use in isolation and detection of microorganisms in fluids; hemodialysis membrane; calculating viral load |
| 03/24/2005 | US20050064581 label-free detector for measuring a property of an analyte; comprises at least one suspended beam connected to two mechanically stable supports; micro-electro-mechanical system (MEMS) |
| 03/24/2005 | US20050064572 Lipid kinase |
| 03/24/2005 | US20050064558 Chimeric polypeptide comprising functional differentially spliced interleukin receptor and b-cell differentiation factor for enhancing expression of interferon inducible protein (IP-10) and macrophage inflammarory proteins for use in treatment of viral diseases |
| 03/24/2005 | US20050064548 Yeast ectopically expressing abnormally processed proteins and uses therefor |
| 03/24/2005 | US20050064544 Nucleotide sequences coding kinase for use as tool in identifying modulator for treatment and prevention of respiratory, cell proliferative, prostate, mammary gland and muscle disorders |
| 03/24/2005 | US20050064543 Secreted proteins |
| 03/24/2005 | US20050064537 Molecular weight markers for western blot |
| 03/24/2005 | US20050064534 Using microscopic systems to monitoring f-actin and myosin activity in cells; monitoring biopolymer transfer between membrane walls |
| 03/24/2005 | US20050064533 Asparagine hydroxylation of the cad domain of a hif protein |
| 03/24/2005 | US20050064531 Methods for screening and identifying compounds |
| 03/24/2005 | US20050064530 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 03/24/2005 | US20050064529 Detection device comprising planar occlusive backing and reporter system for use as tool in monitoring analyte binding; blood glucose monitor |
| 03/24/2005 | US20050064528 Non-or minimally invasive monitoring methods |
| 03/24/2005 | US20050064527 Identifying modulator of activity of newly identified multiple antibiotic resistance (mar) locus regulated (NIMR) gene products; microbiocides; bactericides |
| 03/24/2005 | US20050064525 Method of screening pigs for resistance to salmonellosis |
| 03/24/2005 | US20050064524 Cell for use as tools in analyte detection; biosensor for screening quality of food and water |
| 03/24/2005 | US20050064523 Using endothelial growth factor receptor and slectin concentration as diagnostic indicator of a cells angiogenic status; for use in tissue growth, remodeling and wound healing |